If approved, Mavenclad could offer a more patient-friendly ... EUSA Pharma gets another cancer drug recommended And EUSA Pharma, an up-and-coming niche player in cancer, saw its Fotivda (tivozanib ...

Mitoxantrone hydrochloride is an infused medication originally used to treat cancer. Now ... immune system cells and chemicals. Cladribine (Mavenclad) is a pill that you take for a total of ...

In multiple sclerosis (MS), a person's immune system attacks the protective covering (myelin sheath) of nerve fibers in the brain and spinal cord (central nervous system). MS disease-modifying ...

It may also lower your body's resistance to infections and cancer. People with kidney problems and those who are pregnant or breastfeeding shouldn't take Mavenclad. A drug infusion is delivered ...

and kidney cancer was significantly increased in MS… A sublingual formulation of cladribine, which is the active ingredient of the approved oral treatment Mavenclad, in relapsing multiple ...

Feb. 7, 2025 — Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to ... Personalized Cancer ...

Jan. 15, 2025 — In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive ...

While there currently isn’t a cure for cancer, researchers are exploring several new treatments, including vaccines and gene editing, that could eventually change the face of cancer treatment.

Neither here nor there? Your mind wanders as the moon and Jupiter clash. Find an anchor point. The vibes are high, and your mood is restless. If you don’t ground down, you risk getting drawn ...

Ear cancer is when abnormal cells in the ear start to grow and divide in an uncontrolled way. Most of these cancers start in the skin of the outer ear. Cancers that develop inside the ear, known as ...